Showing 1 - 4 of 4 Items
Showing 1 - 4 of 4 Items
Sort By: Relevance
Protocol
|Research Protocol
2018-07-01
2018-07-01
Primary Objective: To measure the prevalence of molecular markers of SP resistant malaria in North and South Kivu, DRC.
Sulfadoxine/pyrimethamine (SP) forms the backbone of mos...
Sulfadoxine/pyrimethamine (SP) forms the backbone of mos...
Journal Article
|Research
2016-09-06 • Malaria Journal
2016-09-06 • Malaria Journal
BACKGROUND
Between 2009 and 2012, malaria cases diagnosed in a Médecins sans Frontières programme have increased fivefold in Baraka, South Kivu, Democratic Republic of the Congo (DRC...
Between 2009 and 2012, malaria cases diagnosed in a Médecins sans Frontières programme have increased fivefold in Baraka, South Kivu, Democratic Republic of the Congo (DRC...
Protocol
|Research Protocol
2014-06-01
2014-06-01
PRIMARY OBJECTIVES of study:
To compare the in vivo efficacy of artesunate-amodiaquine (ASAQ) versus artemether-lumefantrine (Coartem®) in a population of children aged between 6 an...
To compare the in vivo efficacy of artesunate-amodiaquine (ASAQ) versus artemether-lumefantrine (Coartem®) in a population of children aged between 6 an...
Journal Article
|Research
2019-07-05 • Malaria Journal
2019-07-05 • Malaria Journal
BACKGROUND
Therapeutic efficacy studies in uncomplicated Plasmodium falciparum malaria are confounded by new infections, which constitute competing risk events since they can potenti...
Therapeutic efficacy studies in uncomplicated Plasmodium falciparum malaria are confounded by new infections, which constitute competing risk events since they can potenti...